Analytical Data
-
Gene name
F3
- Application
-
Alternative Names
F3;Semaphorin-3F
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P13726
-
Expression Region
1-295aa
-
AA Sequence
METPAWPRVPRPETAVARTLLLGWVFAQVAGASGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECMGQEKGEFREIFYIIGAVVFVVIILVIILAISLHKCRKAGVGQSWKENSPLNVS
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
F3 recombinant proteins are derived from the F3 protein, which has been identified as a key player in various biological processes, including cell adhesion, proliferation, and differentiation. This protein is particularly notable in the context of cancer research, where it plays a role in tumor development and metastasis. Researchers have been increasingly interested in producing recombinant forms of F3 to further investigate its function and therapeutic potential. The production of F3 recombinant proteins allows for the study of protein interactions, binding mechanisms, and the effects of post-translational modifications. It also provides a platform for developing targeted therapies, as F3 is implicated in specific signaling pathways that can be exploited for drug development. Furthermore, recombinant F3 proteins can serve as valuable tools in diagnostic assays and in the development of vaccines, given their immunogenic properties. The ongoing research in this field is aimed at elucidating the precise mechanisms through which F3 influences cellular behavior and its potential implications for treating diseases characterized by aberrant cell signaling and growth. As such, the exploration of F3 recombinant proteins represents a promising frontier in molecular biology and therapeutic innovation.
